YU108291A - Postupak za dobijanje farmaceutskih kombinacijskih preparata koji sadrže cefalosporinske i ksantinske derivate - Google Patents

Postupak za dobijanje farmaceutskih kombinacijskih preparata koji sadrže cefalosporinske i ksantinske derivate

Info

Publication number
YU108291A
YU108291A YU108291A YU108291A YU108291A YU 108291 A YU108291 A YU 108291A YU 108291 A YU108291 A YU 108291A YU 108291 A YU108291 A YU 108291A YU 108291 A YU108291 A YU 108291A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical combination
procedure
preparations containing
combination preparations
obtaining pharmaceutical
Prior art date
Application number
YU108291A
Other languages
English (en)
Other versions
YU48415B (sh
Inventor
N. Klesel
M. Limbert
E. Schrinner
Original Assignee
Taiho Pharmaceutical Co.Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co.Ltd. filed Critical Taiho Pharmaceutical Co.Ltd.
Priority to HRP-1082/91A priority Critical patent/HRP940708B1/xx
Publication of YU108291A publication Critical patent/YU108291A/sh
Publication of YU48415B publication Critical patent/YU48415B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

POSTUPAK ZA DOBIJANJE FARMACEUTSKIH KOMBINACIJSKIH PREPARATA KOJI SADRŽE CEFALOSPORINSKE I KSANTINSKE DERIVATE, postupak je definisan time da se jedan cefalosporinski derivat i jedan ksantinski derivat zajedno sa primerenim pomoćnim sredstvima i/ili nosačima prevode u oblik pogodan za upotrebu. Od cefalosporinskih derivata koji se upotrebjavaju u predloženom postupku, prvenstveni su: Cefotaxim, Cefodizim, Cefirom, Cefotiam, Cefoperazon, Cefpirom, Cefuroksim, Ceftiroxim, Ceftazidim ili Cefepim a od ksantinskih derivata: Propentofilin a pre svega Pentoksilin. Pomoćna sredstva su iz grupe nosača, konzervansa i dr. kao što su: skrob od krompira, kukuruza ili pšenični skrob, celuloza ili njeni derivati; silicijum dioksid; šećeri kao mlečni šećer; magnezijum karbonat ili kalcijum fosfat. Radi poboljšanja podnošljivosti preparata prvenstveno se dodaju pomoćne materije za stvaranje sluzi i smole.
YU108291A 1990-06-20 1991-06-19 Postupak za dobijanje farmaceutskih kombinacijskih preparata koji sadrže cefalosporinske i ksantinske derivate YU48415B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-1082/91A HRP940708B1 (en) 1990-06-20 1994-10-19 Pharmaceutical preparations of mixtures comprising derivatives of cephalosporin and xantine and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4019571A DE4019571A1 (de) 1990-06-20 1990-06-20 Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung

Publications (2)

Publication Number Publication Date
YU108291A true YU108291A (sh) 1995-03-27
YU48415B YU48415B (sh) 1998-07-10

Family

ID=6408686

Family Applications (1)

Application Number Title Priority Date Filing Date
YU108291A YU48415B (sh) 1990-06-20 1991-06-19 Postupak za dobijanje farmaceutskih kombinacijskih preparata koji sadrže cefalosporinske i ksantinske derivate

Country Status (26)

Country Link
US (1) US5350753A (sh)
EP (1) EP0462506B1 (sh)
JP (1) JP3213339B2 (sh)
KR (1) KR100205161B1 (sh)
CN (1) CN1057390A (sh)
AT (1) ATE144901T1 (sh)
AU (1) AU643291B2 (sh)
BR (1) BR9102554A (sh)
CA (1) CA2044977A1 (sh)
CZ (1) CZ282285B6 (sh)
DE (2) DE4019571A1 (sh)
DK (1) DK0462506T3 (sh)
ES (1) ES2093656T3 (sh)
FI (1) FI912968A (sh)
GR (1) GR3021568T3 (sh)
HR (1) HRP940708B1 (sh)
HU (1) HU212937B (sh)
IE (1) IE76290B1 (sh)
IL (1) IL98535A (sh)
MX (1) MX26309A (sh)
NO (1) NO912382L (sh)
NZ (1) NZ238580A (sh)
PT (1) PT98028B (sh)
RU (1) RU2095063C1 (sh)
YU (1) YU48415B (sh)
ZA (1) ZA914709B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1090795A (en) 1993-11-12 1995-05-29 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
PT812844E (pt) 1996-06-07 2003-03-31 Hoechst Ag Utilizacao de derivados de teofilina para o tratamento e profilaxia de estados de choque novos compostos de xantina e processo para a sua preparacao
JP2006510357A (ja) * 2002-11-22 2006-03-30 ザ ジョーンズ ホプキンズ ユニバーシティ 認識障害の処置のための標的
KR101315483B1 (ko) 2011-06-23 2013-10-07 주식회사 아리바이오 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel

Also Published As

Publication number Publication date
DE59108321D1 (de) 1996-12-12
CS187891A3 (en) 1992-02-19
DE4019571A1 (de) 1992-01-02
CZ282285B6 (cs) 1997-06-11
JP3213339B2 (ja) 2001-10-02
HRP940708B1 (en) 1998-12-31
PT98028A (pt) 1992-03-31
HU912048D0 (en) 1991-12-30
BR9102554A (pt) 1992-01-21
FI912968A (fi) 1991-12-21
CA2044977A1 (en) 1991-12-21
IL98535A0 (en) 1992-07-15
KR100205161B1 (ko) 1999-07-01
US5350753A (en) 1994-09-27
EP0462506B1 (de) 1996-11-06
KR920000322A (ko) 1992-01-29
HU212937B (en) 1996-12-30
HUT57986A (en) 1992-01-28
FI912968A0 (fi) 1991-06-18
YU48415B (sh) 1998-07-10
EP0462506A1 (de) 1991-12-27
IE76290B1 (en) 1997-10-08
NZ238580A (en) 1993-10-26
ZA914709B (en) 1992-03-25
AU7848291A (en) 1992-01-02
IE912107A1 (en) 1992-01-01
DK0462506T3 (da) 1996-11-25
NO912382L (no) 1991-12-23
ES2093656T3 (es) 1997-01-01
HRP940708A2 (en) 1997-02-28
GR3021568T3 (en) 1997-02-28
PT98028B (pt) 1998-11-30
CN1057390A (zh) 1992-01-01
JPH04230219A (ja) 1992-08-19
RU2095063C1 (ru) 1997-11-10
NO912382D0 (no) 1991-06-19
ATE144901T1 (de) 1996-11-15
IL98535A (en) 1996-01-19
MX26309A (es) 1994-02-28
AU643291B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
NZ217016A (en) Zwitterionic bicyclic heterocyclic compounds, and pharmaceutical compositions containing such
FI891986A (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
YU108291A (sh) Postupak za dobijanje farmaceutskih kombinacijskih preparata koji sadrže cefalosporinske i ksantinske derivate
FI884960A0 (fi) Anvaendning av 2-pyrimidinyl-1-piperazin-derivat.
NO922635D0 (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
IT9019882A1 (it) Composizioni farmaceutiche comprendenti derivati del glicerolo-5- fosfato atte al trattamento di patologie del sistema nervoso
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
IT1248485B (it) Derivati della 1,4-benzotiazina ad azione immunostimolante e immonomodulatrice
ITMI920878A1 (it) Composizioni farmaceutiche comprendenti derivati monosialogangliosidici atte al trattamento del danno al midollo spinale.
TR199701299A2 (xx) Vinilpirrolidon sefalasporin türevleri.
ITMI910881A0 (it) Composizioni farmaceutiche comprendenti derivati del glicerolo-3- fosfato atte al trattamento di patologie del sistema nervoso